The application of this compound hindered tumor development and decreased the production of phosphorylated LPR6, phosphorylate and unphosphorylated DVL2, Ser9 phosphorylated GSK3β, active β-catenin, and cyclin D1 [27]. Here, CCND1 is linked to neoplasm.